Spikevax

Overview

Moderna's original COVID-19 mRNA vaccine (mRNA-1273), the product that validated mRNA vaccines at global scale. Now sold as a seasonal respiratory vaccine and the company's largest historical revenue driver.

Fully FDA-approved (2022) and marketed globally as a seasonal COVID-19 vaccine; increasingly complemented by the next-generation mNEXSPIKE.

Key Specs